Genomic investigation and clinical correlates of the in vitro ß-lactam: NaHCO3 responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial.

Petersiel, Neta; Giulieri, Stefano; Daniel, Diane S; Fan, Sook-Ha; Ersoy, Selvi C; Davis, Joshua S; Bayer, Arnold S; Howden, Benjamin P; Tong, Steven Y C

Genomic investigation and clinical correlates of the in vitro ß-lactam: NaHCO₃ responsiveness phenotype among methicillin-resistant Staphylococcus aureus isolates from a randomized clinical trial.

Petersiel, Neta; Giulieri, Stefano; Daniel, Diane S; Fan, Sook-Ha; Ersoy, Selvi C; Davis, Joshua S; Bayer, Arnold S; Howden, Benjamin P; Tong, Steven Y C.

Afiliação

Petersiel N; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Giulieri S; Department of Infectious Diseases, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Daniel DS; Victorian Infectious Diseases Service, The Royal Melbourne Hospital, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Fan S-H; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Ersoy SC; Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Davis JS; Microbiological Diagnostic Unit Public Health Laboratory, Department of Microbiology and Immunology, University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia.
Bayer AS; The Lundquist Institute for Biomedical Innovation, Torrance, California, USA.
Howden BP; The Lundquist Institute for Biomedical Innovation, Torrance, California, USA.
Tong SYC; Menzies School of Health Research and Charles Darwin University, Darwin, Northern Territory, Australia.

Antimicrob Agents Chemother ; 68(7): e0021824, 2024 Jul 09.

Article em En | MEDLINE | ID: mdl-38837393

Assuntos

Antibacterianos; Cefazolina; Staphylococcus aureus Resistente à Meticilina; Testes de Sensibilidade Microbiana; Oxacilina; Infecções Estafilocócicas; Staphylococcus aureus Resistente à Meticilina/efeitos dos fármacos; Staphylococcus aureus Resistente à Meticilina/genética; Humanos; Antibacterianos/farmacologia; Antibacterianos/uso terapêutico; Cefazolina/farmacologia; Cefazolina/uso terapêutico; Infecções Estafilocócicas/tratamento farmacológico; Infecções Estafilocócicas/microbiologia; Oxacilina/farmacologia; Bacteriemia/tratamento farmacológico; Bacteriemia/microbiologia; Fenótipo; beta-Lactamas/farmacologia; beta-Lactamas/uso terapêutico; Masculino; Bicarbonato de Sódio/farmacologia; Feminino; Pessoa de Meia-Idade

Palavras-chave

MRSA; bacterial genomics; bloodstream-infections; methicillin-resistant Staphylococcus aureus; sodium bicarbonate (NaHCO3); ß-lactams

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Oxacilina / Infecções Estafilocócicas / Testes de Sensibilidade Microbiana / Cefazolina / Staphylococcus aureus Resistente à Meticilina / Antibacterianos Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google